Lyell Immunopharma OverviewLyell Immunopharma Other Income Expense Net
Other Income/Expense Net for LYEL.
Quarterly Other Income/Expense
-$22.26M
↓ 530.34% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$335.39M
↓ 1306.71% YoY
Trailing 12 months ending Mar 31, 2026